Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott J Myers

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Neurocritical Care|January 15, 2014
pH-sensitive NMDA inhibitors improve outcome in a murine model of SAHHaichen Wang, Michael L James, Talaignair N Venkatraman, et al.
Nature Communications|January 20, 2019
Structural elements of a pH-sensitive inhibitor binding site in NMDA receptorsMichael C Regan, Zongjian Zhu, Hongjie Yuan, et al.
Epilepsia|August 19, 2022
Compound-heterozygous GRIN2A null variants associated with severe developmental and epileptic encephalopathyVincent Strehlow, Claudine Rieubland, Sabina Gallati, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2018
A novel missense mutation in GRIN2A causes a nonepileptic neurodevelopmental disorderAna Fernández-Marmiesse, Hirofumi Kusumoto, Saray Rekarte, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Di-aryl Sulfonamide Motif Adds π-Stacking Bulk in Negative Allosteric Modulators of the NMDA ReceptorSamantha L Summer, Steven A Kell, Zongjian Zhu, et al.
Pharmacological Reviews|August 19, 2010
Glutamate receptor ion channels: structure, regulation, and functionStephen F Traynelis, Lonnie P Wollmuth, Chris J McBain, et al.
Glia|May 21, 2011
Transcription factor p53 influences microglial activation phenotypeSuman Jayadev, Nicole K Nesser, Stephanie Hopkins, et al.
ACS Chemical Neuroscience|February 13, 2023
Novel GluN2B-Selective NMDA Receptor Negative Allosteric Modulator Possesses Intrinsic Analgesic Properties and Enhances Analgesia of Morphine in a Rodent Tail Flick Pain ModelLynnea D Harris, Michael C Regan, Scott J Myers, et al.
Human Molecular Genetics|June 27, 2023
Classification of missense variants in the N-methyl-d-aspartate receptor GRIN gene family as gain- or loss-of-functionScott J Myers, Hongjie Yuan, Riley E Perszyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 8, 2021
A Glutamate <i>N</i>-Methyl-d-Aspartate (NMDA) Receptor Subunit 2B-Selective Inhibitor of NMDA Receptor Function with Enhanced Potency at Acidic pH and Oral Bioavailability for Clinical UseScott J Myers, Kamalesh P Ruppa, Lawrence J Wilson, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Neurocritical Care|January 15, 2014
pH-sensitive NMDA inhibitors improve outcome in a murine model of SAHHaichen Wang, Michael L James, Talaignair N Venkatraman, et al.
Nature Communications|January 20, 2019
Structural elements of a pH-sensitive inhibitor binding site in NMDA receptorsMichael C Regan, Zongjian Zhu, Hongjie Yuan, et al.
Epilepsia|August 19, 2022
Compound-heterozygous GRIN2A null variants associated with severe developmental and epileptic encephalopathyVincent Strehlow, Claudine Rieubland, Sabina Gallati, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2018
A novel missense mutation in GRIN2A causes a nonepileptic neurodevelopmental disorderAna Fernández-Marmiesse, Hirofumi Kusumoto, Saray Rekarte, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Di-aryl Sulfonamide Motif Adds π-Stacking Bulk in Negative Allosteric Modulators of the NMDA ReceptorSamantha L Summer, Steven A Kell, Zongjian Zhu, et al.
Pharmacological Reviews|August 19, 2010
Glutamate receptor ion channels: structure, regulation, and functionStephen F Traynelis, Lonnie P Wollmuth, Chris J McBain, et al.
Glia|May 21, 2011
Transcription factor p53 influences microglial activation phenotypeSuman Jayadev, Nicole K Nesser, Stephanie Hopkins, et al.
ACS Chemical Neuroscience|February 13, 2023
Novel GluN2B-Selective NMDA Receptor Negative Allosteric Modulator Possesses Intrinsic Analgesic Properties and Enhances Analgesia of Morphine in a Rodent Tail Flick Pain ModelLynnea D Harris, Michael C Regan, Scott J Myers, et al.
Human Molecular Genetics|June 27, 2023
Classification of missense variants in the N-methyl-d-aspartate receptor GRIN gene family as gain- or loss-of-functionScott J Myers, Hongjie Yuan, Riley E Perszyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 8, 2021
A Glutamate <i>N</i>-Methyl-d-Aspartate (NMDA) Receptor Subunit 2B-Selective Inhibitor of NMDA Receptor Function with Enhanced Potency at Acidic pH and Oral Bioavailability for Clinical UseScott J Myers, Kamalesh P Ruppa, Lawrence J Wilson, et al.
Pageof 5